Amy McMichael, MD, presented on photoprotection at the Skin of Color Update. She discussed hot topics and misunderstandings regarding sunscreen use among patients with skin of color in an interview with The Dermatologist.
Although Mohs micrographic surgery is considered standard treatment for several skin cancers, it is not necessarily the best appropriate for every situation. In an interview with The Dermatologist, Dr Sailesh Konda and Dr Vishal Patel discussed considerations for when and when not to perform Mohs surgery.
The American Society for Radiation Oncology created guidelines for the use of radiation therapy for the treatment of basal cell and cutaneous squamous cell carcinomas in patients who are contraindicated or do not want surgery. Corresponding author Dr Anna Likhacheva discussed these guidelines with The Dermatologist.
While the risk of skin cancer is low among patients with skin of color, patients are still at risk for developing both melanoma and non-melanoma skin cancers. Henry Lim, MD, discusses common presentations of skin cancer among patients with skin of color, the importance of sun protection, and tips for patients who are following the latest bad press on sunscreens.
The Dermatologist spoke with David G. Strauss, MD, PhD, with the Division of Applied Regulatory Science at the FDA, about the implications of a recent study that found 4 active ingredients exceeded the maximal thresholds for systemic absorption.
As summer approaches, patients may be especially inclined to seek advice from their dermatologists on appropriate sun protection. Rita Pichardo, MD, from Wake Forest School of Medicine, discusses how dermatologists can educate patients on sunscreen types for year-round use and appropriate application.
A recent article, published in the Journal of American Academy of Dermatology, suggests an optimized approach for conducting skin exams that could reduce wasted time and movements while also improving accuracy. Corresponding author, Matthew Helm, MD, discusses this approach.
The Dermatologist spoke with Adam Friedman, MD, FAAD, professor of dermatology at George Washington School of Medicine and Health Science and director of the supportive oncodermatology clinic, about supportive oncodermatology and its role in cancer treatment.